CYCLERION THERAPEUTICS, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
CYCLERION THERAPEUTICS, INC. (CYCN) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $5.09 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-04
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $5.09M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6.79M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $9.09M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $9.54M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | $5.09M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $6.79M 10-Q · filed 2026-08-04 |
| 2025-12-31 | $9.09M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $9.54M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $8.57M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $8.78M 10-Q · filed 2026-08-04 |
| 2024-12-31 | $8.85M 10-Q · filed 2026-08-04 |
| 2024-09-30 | $8.20M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $8.78M 10-Q · filed 2025-11-12 |
| 2024-03-31 | $9.92M 10-Q · filed 2025-11-12 |
| 2023-12-31 | $11.29M S-4/A · filed 2026-07-22 |
| 2022-12-31 | $10.45M 10-K/A · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |